181 related articles for article (PubMed ID: 22883456)
21. FDG-PET/CT during concomitant chemo radiotherapy for esophageal cancer: Reducing target volumes to deliver higher radiotherapy doses.
Nkhali L; Thureau S; Edet-Sanson A; Doyeux K; Benyoucef A; Gardin I; Michel P; Vera P; Dubray B
Acta Oncol; 2015 Jun; 54(6):909-15. PubMed ID: 25417733
[TBL] [Abstract][Full Text] [Related]
22. Pretreatment (18)F-FDG uptake heterogeneity can predict survival in patients with locally advanced nasopharyngeal carcinoma--a retrospective study.
Yang Z; Shi Q; Zhang Y; Pan H; Yao Z; Hu S; Shi W; Zhu B; Zhang Y; Hu C
Radiat Oncol; 2015 Jan; 10():4. PubMed ID: 25566697
[TBL] [Abstract][Full Text] [Related]
23. [The values of MRI, CT, and PET-CT in detecting retropharyngeal lymph node metastasis of nasopharyngeal carcinoma].
Tang LL; Ma J; Chen Y; Zong JF; Sun Y; Wang Y; Wu HB; Cui NJ
Ai Zheng; 2007 Jul; 26(7):737-41. PubMed ID: 17626750
[TBL] [Abstract][Full Text] [Related]
24. High FDG uptake areas on pre-radiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for locally advanced oesophageal cancer.
Calais J; Dubray B; Nkhali L; Thureau S; Lemarignier C; Modzelewski R; Gardin I; Di Fiore F; Michel P; Vera P
Eur J Nucl Med Mol Imaging; 2015 May; 42(6):858-67. PubMed ID: 25680400
[TBL] [Abstract][Full Text] [Related]
25. Measuring tumor cell proliferation with 18F-FLT PET during radiotherapy of esophageal squamous cell carcinoma: a pilot clinical study.
Yue J; Chen L; Cabrera AR; Sun X; Zhao S; Zheng F; Han A; Zheng J; Teng X; Ma L; Ma Y; Han D; Zhao X; Mu D; Yu J; Li Y
J Nucl Med; 2010 Apr; 51(4):528-34. PubMed ID: 20237030
[TBL] [Abstract][Full Text] [Related]
26. ¹⁸F-FDG PET-CT during chemo-radiotherapy in patients with non-small cell lung cancer: the early metabolic response correlates with the delivered radiation dose.
Massaccesi M; Calcagni ML; Spitilli MG; Cocciolillo F; Pelligrò F; Bonomo L; Valentini V; Giordano A
Radiat Oncol; 2012 Jul; 7():106. PubMed ID: 22781363
[TBL] [Abstract][Full Text] [Related]
27. Preliminary study of 11C-choline PET/CT for T staging of locally advanced nasopharyngeal carcinoma: comparison with 18F-FDG PET/CT.
Wu HB; Wang QS; Wang MF; Zhen X; Zhou WL; Li HS
J Nucl Med; 2011 Mar; 52(3):341-6. PubMed ID: 21321282
[TBL] [Abstract][Full Text] [Related]
28. [Clinical application of (18)F-FDG PET/CT to staging and treatment effectiveness monitoring of nasopharyngeal carcinoma].
Wang GH; Lau EW; Shakher R; Binns DS; Hogg A; Drummond E; Hicks RJ
Ai Zheng; 2007 Jun; 26(6):638-42. PubMed ID: 17562272
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of 18F-FDG PET-CT metabolic index for nasopharyngeal carcinoma.
Xie P; Yue JB; Zhao HX; Sun XD; Kong L; Fu Z; Yu JM
J Cancer Res Clin Oncol; 2010 Jun; 136(6):883-9. PubMed ID: 19936788
[TBL] [Abstract][Full Text] [Related]
30. Impact of radiation dose and standardized uptake value of (18)FDG PET on nodal control in locally advanced cervical cancer.
Ramlov A; Kroon PS; Jürgenliemk-Schulz IM; De Leeuw AA; Gormsen LC; Fokdal LU; Tanderup K; Lindegaard JC
Acta Oncol; 2015; 54(9):1567-73. PubMed ID: 26271799
[TBL] [Abstract][Full Text] [Related]
31. Clinical significance of the post-radiotherapy
Jeong Y; Jung IH; Kim JS; Chang SK; Lee SW
Br J Radiol; 2019 Oct; 92(1102):20180045. PubMed ID: 30102562
[TBL] [Abstract][Full Text] [Related]
32. Pretreatment (18)F-FDG PET standardized uptake value of primary tumor and neck lymph nodes as a predictor of distant metastasis for patients with nasopharyngeal carcinoma.
Hung TM; Wang HM; Kang CJ; Huang SF; Liao CT; Chan SC; Ng SH; Chen IH; Lin CY; Fan KH; Chang JT
Oral Oncol; 2013 Feb; 49(2):169-74. PubMed ID: 23063613
[TBL] [Abstract][Full Text] [Related]
33. PET/CT for staging and follow-up of pediatric nasopharyngeal carcinoma.
Cheuk DK; Sabin ND; Hossain M; Wozniak A; Naik M; Rodriguez-Galindo C; Krasin MJ; Shulkin BL
Eur J Nucl Med Mol Imaging; 2012 Jul; 39(7):1097-106. PubMed ID: 22532252
[TBL] [Abstract][Full Text] [Related]
34. Positive clinical impact of an additional PET/CT scan before adjuvant radiotherapy or concurrent chemoradiotherapy in patients with advanced oral cavity squamous cell carcinoma.
Kang CJ; Lin CY; Yang LY; Ho TY; Lee LY; Fan KH; Wang HM; Huang SF; Chang KP; Fang KH; Ng SH; Liao CT; Yen TC
J Nucl Med; 2015 Jan; 56(1):22-30. PubMed ID: 25525186
[TBL] [Abstract][Full Text] [Related]
35. Early monitoring of radiotherapeutic effects of nasopharyngeal carcinoma xenografts in nude mice using 18F-FDG PET-CT imaging.
Yuan JW; Fen YL; Xian WJ; He XH; Yuan BH; Ye QL
Chin J Cancer; 2010 Apr; 29(4):374-8. PubMed ID: 20346211
[TBL] [Abstract][Full Text] [Related]
36. Impact of positron emission tomography with the use of fluorodeoxyglucose on response to induction chemotherapy in patients with oropharyngeal and hypopharyngeal squamous cell carcinoma.
Kawakita D; Masui T; Hanai N; Ozawa T; Hirakawa H; Terada A; Nishio M; Hosoi H; Hasegawa Y
Acta Otolaryngol; 2013 May; 133(5):523-30. PubMed ID: 23679812
[TBL] [Abstract][Full Text] [Related]
37. Role of chemoradiotherapy in intermediate prognosis nasopharyngeal carcinoma.
Xu T; Hu C; Wang X; Shen C
Oral Oncol; 2011 May; 47(5):408-13. PubMed ID: 21459659
[TBL] [Abstract][Full Text] [Related]
38. Early evaluation of the response to radiotherapy of patients with squamous cell carcinoma of the head and neck using 18FDG-PET.
Nam SY; Lee SW; Im KC; Kim JS; Kim SY; Choi SH; Ryu JS; Moon DH; Oh SJ; Yi BY; Kim JH; Ahn SD; Shin SS; Kim SB; Choi EK; Lee BJ
Oral Oncol; 2005 Apr; 41(4):390-5. PubMed ID: 15792611
[TBL] [Abstract][Full Text] [Related]
39. (18)F-fluorodeoxyglucose positron emission tomography to assess response after radiation therapy in anaplastic thyroid cancer.
Levy A; Leboulleux S; Lepoutre-Lussey C; Baudin E; Ghuzlan AA; Hartl D; Deutsch E; Deandreis D; Lumbroso J; Tao Y; Schlumberger M; Blanchard P
Oral Oncol; 2015 Apr; 51(4):370-5. PubMed ID: 25595614
[TBL] [Abstract][Full Text] [Related]
40. Biological response of nasopharyngeal carcinoma to radiation therapy: a pilot study using serial 18F-FDG PET/CT scans.
Lin Q; Yang R; Sun L; Chen S; Wu H
Cancer Invest; 2012 Aug; 30(7):528-36. PubMed ID: 22668086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
